High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin
The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Abstract
In thalassemia, deficient globin-chain production during erythropoiesis results in anemia. Thalassemia may be further complicated by iron overload (frequently exacerbated by blood transfusion), which induces numerous endocrine diseases, hepatic cirrhosis, cardiac failure and even death. Accumulation of iron in the absence of blood transfusions may result from inappropriate suppression of the iron-regulating peptide hepcidin by an erythropoietic mechanism. To test this hypothesis, we examined erythroblast transcriptome profiles from 15 healthy, nonthalassemic donors. Growth differentiation factor 15 (GDF15), a member of the transforming growth factor-beta superfamily, showed increased expression and secretion during erythroblast maturation. Healthy volunteers had mean GDF15 serum concentrations of 450 +/- 50 pg/ml. In comparison, individuals with beta-thalassemia syndromes had elevated GDF15 serum levels (mean 66,000 +/- 9,600 pg/ml; range 4,800-248,000 pg/ml; P < 0.05) that were positively correlated with the levels of soluble transferrin receptor, erythropoietin and ferritin. Serum from thalassemia patients suppressed hepcidin mRNA expression in primary human hepatocytes, and depletion of GDF15 reversed hepcidin suppression. These results suggest that GDF15 overexpression arising from an expanded erythroid compartment contributes to iron overload in thalassemia syndromes by inhibiting hepcidin expression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Growth-differentiation factor (GDF)-15, whose levels are increased in thalassemia and AI with or without ID, also inhibits HAMP expression [60, 64].”
From Iron deficiency or anemia of inflammation?: Differential diagnosis and mechanisms of anemia of inflammation (2016) · cites this paper as [60]
In the citing paper
“However, in being the primary iron source for erythropoiesis, TF also indirectly regulates HAMP expression via erythroid progenitor-derived mediators, suggesting that the pathways of HAMP regulation are interconnected [59–61].”
From Iron deficiency or anemia of inflammation?: Differential diagnosis and mechanisms of anemia of inflammation (2016) · cites this paper as [60]
In the citing paper
“Growth differentiation factor 15 (GDF-15) and twisted gastrulation homolog 1 (TWSG1) have been identified as candidate erythrokines, although not erythroblast-specific, that have the potential to suppress hepcidin under conditions of increased erythropoietic activity.”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [214]
In the citing paper
“GDF15 is an iron- and O2-regulated (HIF-independent) member of the TGF-β superfamily, which is secreted from maturing erythroblasts and has been shown to suppress hepcidin transcription in primary human hepatocytes and hepatoma cells”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [214]
In the citing paper
“This is in contrast to previous reports where higher doses of GDF15 were needed to achieve hepcidin suppression in human HuH-7 hepatoma cells and in primary hepatocytes, while low dose GDF15 treatment increased hepcidin.”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [214]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
Weatherall, D. J., & Clegg, J. B. (2001) · Wiley eBooks · doi:10.1002/9780470696705 · Cited by 1,069
Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression
Babitt, J. L., Huang, F. W., Wrighting, D. M., Xia, Y., Sidis, Y., Samad, T. A., Campagna, J. A., Chung, R. T., Schneyer, A. L., Woolf, C. J., et al. (2006) · Nature Genetics · doi:10.1038/ng1777 · Cited by 1,026 · cited 1×
“Recently, transforming growth factor-β (TGFB) superfamily members have been identified as regulators of hepcidin expressio”
BackgroundRund, D., & Rachmilewitz, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050436 · Cited by 939
(1973) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1973.tb111034.x · Cited by 811
Regulation of Iron Metabolism by Hepcidin
Nemeth, E., & Ganz, T. (2006) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.26.061505.111303 · Cited by 756
Self-citationA role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression
Wang, R.-H., Li, C., Xu, X., Zheng, Y., Xiao, C., Zerfas, P., Cooperman, S., Eckhaus, M., Rouault, T., Mishra, L., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.10.010 · Cited by 614 · cited 1×
“Recently, transforming growth factor-β (TGFB) superfamily members have been identified as regulators of hepcidin expressio”
BackgroundSelf-citationXu, J., Kimball, T. R., Lorenz, J. N., Brown, D. A., Bauskin, A. R., Klevitsky, R., Hewett, T. E., Breit, S. N., & Molkentin, J. D. (2006) · Circulation Research · doi:10.1161/01.res.0000202804.84885.d0 · Cited by 506 · cited 1×
“Studies in cardiomyocytes suggest that GDF15 activates Smad2/3 signalin”
BackgroundLarge-Scale Delineation of Secreted Protein Biomarkers Overexpressed in Cancer Tissue and Serum
Welsh, J. B., Sapinoso, L. M., Kern, S. G., Brown, D. A., Liu, T., Bauskin, A. R., Ward, R. L., Hawkins, N. J., Quinn, D. I., Russell, P. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530278100 · Cited by 503 · cited 1×
“Elevated serum GDF15 concentrations have been reported in a variety of cancer”
BackgroundThe transforming growth factor-β superfamily of receptors
de Caestecker, M. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2003.10.004 · Cited by 464
Cited by
Items 501–600 of 865
Green, J. M., Leu, K., Worth, A., Mortensen, R. B., Martinez, D. K., Schatz, P. J., Wojchowski, D. M., & Young, P. R. (2012) · Experimental Hematology · doi:10.1016/j.exphem.2012.02.007 · Cited by 17
“metabolism by modulating the liver expression of hepcidin, namely BMP2 and GDF15, were also found to be modulated by both peginestide and rHuEPO [35–38].”
BackgroundHigh levels of soluble serum hemojuvelin in patients with congenital dyserythropoietic anemia type I
Shalev, H., Perez‐Avraham, G., Kapelushnik, J., Levi, I., Rabinovich, A., Swinkels, D. W., Brasse‐Lagnel, C., & Tamary, H. (2012) · European Journal Of Haematology · doi:10.1111/ejh.12027 · Cited by 19
“The nature of this signal is still unknown, and release of cytokine such as GDF15 (6) or TWSG1 (25) from an expanded erythroid marrow were suggested to mediate such response.”
Hossaini, S. K. E., & Haeri, M. R. (2019) · Journal of Hematopathology · doi:10.1007/s12308-019-00363-x · Cited by 15
Direct modulation of hepatocyte hepcidin signaling by iron
Yu, L., Wang, S., Chen, C., Rausch, V., Elshaarawy, O., & Mueller, S. (2021) · World Journal of Hepatology · doi:10.4254/wjh.v13.i10.1378 · Cited by 17
Kaneko, K., Furuyama, K., Aburatani, H., & Shibahara, S. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.06878.x · Cited by 15
Steensma, D. P. (2011) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-011-0084-z · Cited by 15
“Also, thalassemia promotes vigorous iron absorption from the gut, possibly mediated by high levels of GDF15 expression and consequent hepcidin inhibition [36]; tissue deposition patterns may be different than in MDS.”
BackgroundKawabata, H., Doisaki, S., Okamoto, A., Uchiyama, T., Sakamoto, S., Hama, A., Hosoda, K., Fujikura, J., Kanno, H., Fujii, H., et al. (2012) · Internal Medicine · doi:10.2169/internalmedicine.51.6978 · Cited by 15
“GDF15, a humoral factor belonging to the transforming growth factor-β superfamily, has been shown to suppress hepatic production of hepcidin (13).”
BackgroundIron metabolism in solid‑organ transplantation: how far are we from solving the mystery?
Małyszko, J., Levin-Iaina, N., Myśliwiec, M., Przybyłowski, P., & Durlik, M. (2012) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.1423 · Cited by 16
Aaron, R., George, B., Mathews, V., Srivastava, A., & Edison, E. S. (2014) · Annals of Hematology · doi:10.1007/s00277-014-2113-1 · Cited by 15
“Growth differentiation factor-15 (GDF15), a member of TGF-β super family, has been reported to mediate the suppression of hepcidin in thalassemia [4].”
BackgroundWu, J., Yuan, L., Ma, Z., Chen, X., Gu, L., & Gao, J. (2013) · Pediatric Blood & Cancer · doi:10.1002/pbc.24373 · Cited by 15
“5-fold increase) was much less conspicuous than that in patients with severe thalassemia syndromes characterized by marked ineffective erythropoiesis, which were 5,900 1,200 and 66,000 9,600 pg/ml in severe a and b thalassemia, respectively, up to 13- and 145-fold increase as compared to that in a group of normal volu…”
Tantawy, A. A. G., Adly, A. A. M., Ismail, E. A. R., Darwish, Y. W., & Zedan, M. A. (2014) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2014.07.003 · Cited by 17
Changes in hepatic gene expression in dogs with experimentally induced nutritional iron deficiency
Fry, M. M., Kirk, C. A., Liggett, J. L., Daniel, G. B., Baek, S. J., Gouffon, J. S., Chimakurthy, P. M., & Rekapalli, B. (2009) · Veterinary Clinical Pathology · doi:10.1111/j.1939-165x.2008.00081.x · Cited by 15
Sukumaran, A., James, J., Janardhan, H. P., Amaladas, A., Suresh, L. M., Danda, D., Jeyeseelan, V., Ramakrishna, B. S., & Jacob, M. (2014) · British Journal Of Nutrition · doi:10.1017/s0007114513003334 · Cited by 14
“The latter two are secreted by erythroid precursor cells, with high levels reported in patients with thalassemic syndromes, resulting in the suppression of hepcidin synthesis((28,30)).”
Sulovská, L., Holub, D., Zidova, Z., Divoká, M., Hajdúch, M., Mihál, V., Vrbková, J., Horváthová, M., & Pospíšilová, D. (2015) · Biomedical Papers · doi:10.5507/bp.2015.054 · Cited by 14
Interaction of Transfusion and Iron Chelation in Thalassemias
Porter, J. B., & Garbowski, M. (2018) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2017.11.010 · Cited by 14
A role for hepcidin in the anemia caused by Trypanosoma brucei infection
Neves, J. V., Gomes, A. C., Costa, D. M., Barroso, C., Vaulont, S., Cordeiro‐da‐Silva, A., Tavares, J., & Rodrigues, P. (2020) · Haematologica · doi:10.3324/haematol.2019.227728 · Cited by 14
Ueland, T., Gullestad, L. L., Kou, L., Young, J. B., Pfeffer, M. A., van Veldhuisen, D. J., Swedberg, K. B., McMurray, J. J. V., Desai, A. S., Anand, I. S., et al. (2021) · Clinical Research in Cardiology · doi:10.1007/s00392-021-01944-6 · Cited by 14
“However, the effect of GDF-1 on erythropoiesis is still unclear, and the suppressive effects of GDF-15 on hepcidin were tested in a very different setting (in vitro experiments in hepatocytes) than in HF patients [11].”
BackgroundZhang, H., Zhou, Q., Chen, H., & Lu, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095002 · Cited by 15
Prospects for a hepcidin mimic to treat β-thalassemia and hemochromatosis
Parrow, N. L., Gardenghi, S., & Rivella, S. (2011) · Expert Review of Hematology · doi:10.1586/ehm.11.22 · Cited by 17
Banaszkiewicz, M., Małyszko, J., Batko, K., Koc‐Żórawska, E., Żórawski, M., Dumnicka, P., Jurczyszyn, A. J., Woziwodzka, K., Tisończyk, J., Krzanowski, M., et al. (2020) · Mediators of Inflammation · doi:10.1155/2020/5657864 · Cited by 14
“Recombinant GDF-15 has been reported to inhibit hematopoiesis, which falls in line with negative correlations between hemoglobin and increasing levels of GDF-15 observed at present, as well as in prior works (Toshihiko [37]; Jill Corre, Hébraud, and Bourin 2013; J.”
BackgroundResultLabile plasma iron, more practical and more sensitive to iron overload in myelodysplastic syndromes
Gu, S., Xv, Y., Fei, C., Xiao, C. W., Guo, J., Zhao, Y., Xv, F., Li, X., & Chang, C. (2016) · Hematology · doi:10.1080/10245332.2016.1199178 · Cited by 13
Yazawa, H., Fukuda, T., Kaneda, H., Waku, R., Sakuma, M., Matsumoto, A., Toyoda, S., Abe, S., Nakamura, F., Inoue, T., et al. (2020) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2020.100651 · Cited by 16
“Bone-marrow derived GDF-15 can down-regulate expression of the peptide hormone hepatic hepcidin [21], which inhibits Fe absorption through enterocytes and Fe release from macrophages by inactivating the Fe export pump ferroportin [22].”
BackgroundYamaguchi, Y., Zampino, M., Tanaka, T., Bandinelli, S., Osawa, Y., Ferrucci, L., & Semba, R. D. (2020) · The Journals of Gerontology Series A · doi:10.1093/gerona/glaa324 · Cited by 13
Öztürk, Z., Gümüşlü, S., Yalçın, K., & Küpesiz, A. (2020) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000002046 · Cited by 14
Zheng, J., Wang, J., Ma, H., Shen, M., Qian, Z., & Bao, Y.-X. (2022) · Redox Report · doi:10.1080/13510002.2022.2088011 · Cited by 13
“The expression of TfR1, DMT1 and Fpn1 is coordinately regulated by the IRP/IRE (iron-responsive element) system, [39,40,48,49] positively for the 3′ untranslated region IRE motif in TfR1 and DMT1 and negatively for the 5′ untranslated region IRE motif in Fpn1 (and FTL), namely to up-regulate TfR1 and DMT1 and down-reg…”
BackgroundIron deficiency anemia, anemia of chronic disorders and iron overload
Pippard, M. J. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7020-3147-2.00011-0 · Cited by 15
Iron and the Reticuloendothelial System
Weiß, G. (2011) · Humana Press eBooks · doi:10.1007/978-1-60327-485-2_11 · Cited by 13
GDF15 and Hepcidin as Prognostic Factors in Patients with Prostate Cancer
Boegemann, F. J. W. M. (2014) · Journal of Molecular Biomarkers & Diagnosis · doi:10.4172/2155-9929.1000199 · Cited by 15
“reported that GDF15 can suppress hepcidin in thalassemic anemia [14].”
Teawtrakul, N., Chansai, S., Yamsri, S., Chansung, K., Wanitpongpun, C., Lanamtieng, T., Phiphitaporn, P., Fucharoen, S., & Pongchaiyakul, C. (2023) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2023.05.002 · Cited by 12
Self-citationThompson, P. A., Hsu, C., Green, S., Stopeck, A., Johnson, K. M., Alberts, D. S., & Chow, H. ‐. S. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0120 · Cited by 13
“GDF15 analysis GDF15 content in NAF was determined using the ELISA Builder Human GDF15 DuoSet ELISA (R&D Systems), as described previously (15).”
MethodGu, S., Song, X., Zhao, Y., Guo, J., Fei, C., Xu, F., Wu, L., Zhang, X., Zhao, J., Chang, C., et al. (2013) · Hematology · doi:10.1179/1607845412y.0000000064 · Cited by 13
Li, X., Ying, J., Li, J., Zhu, S.-L., Li, J., & Pai, P. M. (2014) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563214552109 · Cited by 12
“HD patients were further divided into those with GDF-15 concentration <5000 ng/L (subgroup ‘a’, N1⁄4 24) and those with 55000 ng/L (subgroup ‘b’, N1⁄4 8) to determine whether there was an association with hepcidin or iron indices only at higher GDF-15 concentrations (55000 ng/L).(3) Within this subgroup, no correlatio…”
BackgroundMethodInfluentialMiura, S., Kobune, M., Horiguchi, H., Kikuchi, S., Iyama, S., Murase, K., Goto, A., Ikeda, H., Takada, K., Miyanishi, K., et al. (2019) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2019.04.014 · Cited by 12
Molecular basis of hereditary iron homeostasis defects
Horváthová, M., Ponka, P., & Divoký, V. (2010) · Hematology · doi:10.1179/102453310x12583347009810 · Cited by 13
Sebastiani, G., & Pantopoulos, K. (2010) · CRC Press eBooks · doi:10.1201/9781420059984-c13 · Cited by 12
Urinary hepcidin excretion in patients with low grade myelodysplastic syndrome
Murphy, P. T., Mitra, S., Gleeson, M. J., Desmond, R. G., & Swinkels, D. W. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07455.x · Cited by 12
“The mechanism of this suppression of hepcidin production in the presence of functional iron deficiency needs to be further elucidated but may be due to (i) the association of functional iron deficiency with ineffective erythropoiesis that, at least in thalassaemia major, is reported to be related to hepcidin suppressi…”
BackgroundYoshida, S., Saito, T., Shibagaki, K., Hirao, K., Yuza, T., Tomosugi, N., & Honda, H. (2023) · Scientific Reports · doi:10.1038/s41598-023-30331-6 · Cited by 11
Genetic Background of β Thalassemia Modifier: Recent Update
Rujito, L., & Sasongko, T. H. (2018) · Journal of Biomedicine and Translational Research · doi:10.14710/jbtr.v4i1.2541 · Cited by 13
“An abundant expression of GDF15 inhibited hepcidin expression, contributing to iron overload process in thalassemia syndrome.(61) Reducing GDF15 factor may decrease toxicity of iron and contribute to clinical improvement.”
BackgroundPregnancy outcome in women with transfused beta-thalassemia in France
Virot, E., Thuret, I., Mainbourg, S., Herbrecht, R., Lachenal, F., Lionnet, F., Lucchini, M.-J., Machin, J., Nimubona, S., Ribeil, J., et al. (2021) · Annals of Hematology · doi:10.1007/s00277-021-04697-4 · Cited by 12
Ramasamy, J., Jagadish, C., Sukumaran, A., Varghese, J., Mani, T., Joseph, A. J., Simon, E. G., & Jacob, M. (2023) · Inflammation · doi:10.1007/s10753-023-01872-9 · Cited by 14
Horváthová, M., Kapralova, K., Zidova, Z., Doležal, D., Pospíšilová, D., & Divoký, V. (2012) · Haematologica · doi:10.3324/haematol.2011.059550 · Cited by 15
“Tanno et al.(29) demonstrated that significant suppression of hepcidin required a GDF15 level higher than 5000 pg/mL.”
BackgroundVallet, N. (2017) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2017.05.008 · Cited by 16
Riabov, V., Mossner, M., Stöhr, A., Jann, J.-C., Streuer, A., Schmitt, N., Knaflic, A., Nowak, V., Weimer, N., Obländer, J., et al. (2021) · British Journal of Haematology · doi:10.1111/bjh.17314 · Cited by 13
Agarwal, R. G., Khokhar, M., Khokhar, M., Modi, A., Bajpai, N. K., Bohra, G. K., Garg, M. K., & Sharma, P. (2022) · Minerva Endocrinology · doi:10.23736/s2724-6507.22.03646-6 · Cited by 11
Srai, S. K., & Sharp, P. (2011) · Humana Press eBooks · doi:10.1007/978-1-60327-485-2_1 · Cited by 15
Lee, Y. T., Kim, K. S., Byrnes, C., de Vasconcellos, J. F., Noh, S.-J., Rabel, A., Meier, E. R., & Miller, J. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068307 · Cited by 11
“Investigations of erythroblast GDF15 regulation [14] or caspase related GATA-1 expression [33] can be explored further.”
BackgroundMethodSelf-citationCan Serum Gdf-15 be Associated with Functional Iron Deficiency in Hemodialysis Patients?
Yılmaz, H., Çakmak, M., Darçın, T., İnan, O., Bilgiç, M. A., Bavbek, N., & Akçay, A. (2015) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-015-0551-0 · Cited by 11
Acidic milieu augments the expression of hepcidin, the central regulator of iron homeostasis
Mizumoto, C., Kawabata, H., Uchiyama, T., Sakamoto, S., Kanda, J., Tomosugi, N., & Takaori‐Kondo, A. (2012) · International Journal of Hematology · doi:10.1007/s12185-012-1223-6 · Cited by 11
“In patients with b-thalassemia, congenital dyserythropoietic anemia and a subtype of myelodysplastic syndromes, overproduction of growth differentiation factor-15 by erythropoietic cells downregulates hepcidin expression, thereby causing systemic iron overload [15–17].”
BackgroundIron metabolism and maternal-fetal iron circulation
Słomka, A., Żekanowska, E., Piotrowska, K., & Kwapisz, J. (2012) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.5604/17322693.1019651 · Cited by 13
“Wykazano, że duże stężenie czynnika GDF-15 odpowiedzialne jest za zmniejszenie syntezy hepcydyny [97].”
BackgroundIs erythroferrone finally the long sought-after systemic erythroid regulator of iron?
Lawen, A. (2015) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v6.i3.78 · Cited by 13
GDF15: An emerging disease target and biomarker of metabolic diseases
Yang, C., Chen, H., Huang, X., Zhou, L., & Yuan, X. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02636-y · Cited by 13
“At low concentrations (≤ 1,000 pg/ ml), GDF15 promotes hepcidin expression, whereas at higher concentrations (> 10,000 pg/ml), hepcidin expression is significantly suppressed [97].”
EnvIRONmental Aspects in Myelodysplastic Syndrome
Petzer, V., Theurl, I., Weiß, G., & Wolf, D. G. F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105202 · Cited by 10
Parisi, S., & Finelli, C. (2021) · Journal of Blood Medicine · doi:10.2147/jbm.s287876 · Cited by 10
Au, T. Y., Benjamin, S., & Wiśniewski, O. W. (2022) · Thalassemia Reports · doi:10.3390/thalassrep12030017 · Cited by 10
“Interestingly, downstream effects of ineffective erythropoiesis on hepcidin synthesis were initially attributed to twisted gastrulation 1 (TWSG1) and growth differentiation factor 15 (GDF15) [31,32], albeit conflicting views arise in the literature, and future research is needed to clearly elucidate their potential [3…”
BackgroundIron Overload and Platelet Function Defects: Possible Correlation
Dahi, A., Hanafy, E., & Pakra, M. A. (2016) · Journal of Investigative Medicine High Impact Case Reports · doi:10.1177/2324709616675645 · Cited by 10
“Thus, patients who are receiving an average of 2 to 4 units of blood monthly will have an iron intake of 5000 to 10 000 mg of iron per year.(3) Inefficient iron chelation leads to death that occurs from cardiac failure or arrhythmia.”
BackgroundJaspers, A., Baron, F., Willems, E., Seidel, L., Wiegerinck, E. T. G., Swinkels, D. W., & Beguin, Y. P. (2014) · Haematologica · doi:10.3324/haematol.2013.100032 · Cited by 10
Ribeiro, S., Garrido, P., Fernandes, J. C., Rocha, S., Rocha‐Pereira, P., Costa, E. M., Belo, L., Reis, F., & Santos‐Silva, A. (2016) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2016.04.008 · Cited by 10
Novel and innovative approaches for treatment of β-thalassemia
Soni, S. (2017) · Pediatric Hematology Oncology Journal · doi:10.1016/j.phoj.2017.11.153 · Cited by 13
Endocrine complications in patients with β-thalassemia major receiving iron-chelation therapy
Al-Sanabra, O. M., Abbas, M. A., Hazàa, A. A., & Haza, W. J. (2025) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188251406554 · Cited by 9
“This is mainly due to the elevated erythroferrone and growth differentiation factor 15 levels, which inhibit hepcidin by disrupting BMP/SMAD signaling.”
Association of GDF15 levels with body mass index and endocrine status in β‐thalassaemia
Karusheva, Y., Petry, C. J., Yasara, N., Kottahachchi, D., Premawardhena, A., Barker, P. J., Burling, K., Sattar, N. A., Welsh, P. I., Mettananda, S., et al. (2023) · Clinical Endocrinology · doi:10.1111/cen.14897 · Cited by 10
“GDF15 is known to be expressed at high levels in erythroblasts 6 and its expression is highly responsive to a range of cellular stresses 5 several of which are likely to be active in the thalassaemic erythroblast undergoing ineffective erythropoiesis.”
BackgroundFukuda, T., Yazawa, H., Nishikawa, R., Tokoi, S., Kayashima, R., Kono, K., Sakuma, M., Abe, S., Toyoda, S., & Nakajima, T. (2024) · Cureus · doi:10.7759/cureus.60422 · Cited by 11
“The increased GDF-15 level then led to a downregulation of hepcidin expression [10] and promoted iron absorption and iron recirculation in monocytes.”
BackgroundInfluentialGuo, R., Zhang, S., Li, A., Zhang, P., Peng, X., Lu, X., & Fan, X. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107711 · Cited by 9
Hamad, M. A., & Awadallah, S. M. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.10.019 · Cited by 9
“Hypoxia activates a number of proteins like the transcription factor hypoxia inducible factor 1a (HIF-1a) [42] and the growth differentiation factor 15 (GDF15) [43] to downregulate hepcidin synthesis.”
BackgroundIron Overload in Non-Transfusion-Dependent Thalassemia
Musallam, K. M. (2013) · Thalassemia Reports · doi:10.4081/thal.2013.s1.e11 · Cited by 9
“Proposed regulators of hepcidin production include growth differentiation factor-15 (GDF-15) (8-9), twisted gastrulation factor-1 (TWGF-1) (10), hypoxia inducible transcription factors (HIFs) (11), among others (12-13).”
Analysis of protein profiling studies of β‐thalassemia/Hb E disease
Lithanatudom, P., & Smith, D. R. (2016) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201600086 · Cited by 9
“[21] 2012 Platelet free plasma derived microparticles 2-DE and Q-TOF MS and MS/MS 9 reduced expression 11 increased expression 7 only in thalassemiab Weeraphan et al.”
BackgroundMethodThe Re-Emerging Role of Iron in Infection and Immunity
Hamad, M. A., & Bajbouj, K. (2016) · Integrative Molecular Medicine · doi:10.15761/imm.1000251 · Cited by 9
“Increased demand for iron therefore downregulates hepcidin synthesis by upregulating the transcription of hypoxia inducible factor 1α (HIF-1α) [5] and the growth differentiation factor 15 (GDF15) [6] among other mechanism [7].”
BackgroundNSAID-activated gene 1 and its implications for mucosal integrity and intervention beyond NSAIDs
Moon, Y. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.04.023 · Cited by 9
Serum hepcidin assay in 2011: where do we stand?
Delaby, C., & Beaumont, C. (2012) · Annales de biologie clinique · doi:10.1684/abc.2012.0725 · Cited by 12
Lotfi, R., Kroll, C., Plonné, D., Jahrsdörfer, B., & Schrezenmeier, H. (2015) · Transfusion Medicine and Hemotherapy · doi:10.1159/000440825 · Cited by 10
Vokurka, M., Krijt, J., Vávrová, J., & Nečas, E. (2011) · Folia Biologica · doi:10.14712/fb2011057060248 · Cited by 9
“The erythropoietic regulatory pathway includes growth differentiation factor 15 (GDF15) and twisted gastrulation (TWSG1) (Tanno et al., 2007; 2009).”
BackgroundPaterson, A. C., & Pietrangelo, A. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7020-3398-8.00005-2 · Cited by 9
Bloomer, S. A., Olivier, A. K., Bergmann, O. M., Mathahs, M. M., Broadhurst, K. A., Hicsasmaz, H., & Brown, K. E. (2016) · Cell Biochemistry and Function · doi:10.1002/cbf.3238 · Cited by 10
“Moreover, this cytokine has been implicated in the regulation of hepcidin expression.(32) In BALB/c and C57BL/6 mice on the AD for 6 or 18 weeks, gdf15 mRNA levels rose significantly.”
BackgroundLi, L., Wang, X., Zhang, H., Chen, Q., & Cui, H. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173958 · Cited by 10
Zaman, B. A., & Ibrahim, S. (2022) · Hemoglobin · doi:10.1080/03630269.2022.2083969 · Cited by 9
Ribeiro, S., Garrido, P., Fernandes, J. C., Rocha‐Pereira, P., Costa, E. M., Belo, L., Reis, F., & Santos‐Silva, A. (2016) · BioFactors · doi:10.1002/biof.1275 · Cited by 11
Transforming growth factor 15 increased in severe aplastic anemia patients
Shao, Y., Wang, H., Liu, C., Cao, Q., Fu, R., Wang, H., Wang, T., Qi, W., & Shao, Z. (2017) · Hematology · doi:10.1080/10245332.2017.1311462 · Cited by 9
“poiesis, the apoptosis of erythroblasts induces the up-regulation of GDF-15 [16].”
BackgroundALBAYRAK, C., Tarkun, P., Ateşoğlu, E. B., ERALDEMİR, C., Özsoy, Ö. D., Demirsoy, E. T., Mehtap, Ö., Gedük, A., & Hacıhanefioğlu, A. (2019) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1803-13 · Cited by 10
Sanyear, C., Butthep, P., Eamsaard, W., Fucharoen, S., Svasti, S., & Masaratana, P. (2020) · PeerJ · doi:10.7717/peerj.8802 · Cited by 9
“…differentiation factor 15 (Gdf15), twisted gastrulation 1 (Twsg1) and erythroferrone (Erfe) which are produced by erythroid precursors have been proposed to be potential candidates for hepcidin regulator under such conditions including thalassemia (Tanno et al., 2007, 2009; Kautz et al., 2014).”
BackgroundSelf-citationCrosstalk between Erythropoiesis and Iron Metabolism
Rivella, S., Nemeth, E., & Miller, J. L. (2010) · Advances in Hematology · doi:10.1155/2010/317095 · Cited by 9
“Also GDF15 could be another potential therapeutic target for beta-thalassemia syndromes [85].”
BackgroundInfluentialSelf-citationMegaloblastic anemia-related iron overload and erythroid regulators: a case report
Vallet, N., Delaye, J.-B., Ropert, M., Foucault, A., Ravalet, N., Deriaz, S., Chalopin, T., Blasco, H., Maillot, F., Hérault, O., et al. (2021) · Journal of Medical Case Reports · doi:10.1186/s13256-021-03065-0 · Cited by 9
“In ineffective erythropoiesis, hepcidin synthesis is suppressed by erythroid regulators, namely erythroferrone (ERFE) [3] and growth differentiation factor-15 (GDF15) [4].”
BackgroundMolecular insights into placental iron transfer mechanisms and maternofetal regulation
Santhakumar, S., & Edison, E. S. (2023) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-023-07032-6 · Cited by 8
“Erythroid derived cytokines like growth differentiation factor 15 (GDF15), twisted gastrulation homolog 1 (TWSG1) and erythroferrone (ERFE) are considered hepcidin suppressors in the setting of increased erythropoiesis [52–54].”
Impaired bone marrow microenvironment and stem cells in transfusion-dependent beta-thalassemia
Zhou, X., Huang, L., Wu, J., Qu, Y., Jiang, H., Zhang, J., Qiu, S., Liao, C., Xu, X. M., Xia, J., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112548 · Cited by 9
Specific Changes of Erythroid Regulators and Hepcidin in Patients Infected by SARS-COV-2
Delaye, J.-B., Alarcan, H., Vallet, N., Veyrat‐Durebex, C., Bernard, L., Hérault, O., Ropert, M., Marlet, J., Gyan, E., Andres, C. R., et al. (2022) · Journal of Investigative Medicine · doi:10.1136/jim-2021-002270 · Cited by 8
Vallelian, F., Gelderman-Fuhrmann, M. P., Schaer, C. A., Puglia, M., Opitz, L., Baek, J. H., Vostal, J. G., Buehler, P. W., & Schaer, D. J. (2015) · Journal of Proteome Research · doi:10.1021/pr5010778 · Cited by 8
Heme metabolism as an integral part of iron homeostasis
Lipiński, P., Starzyński, R. R., Styś, A., Gajowiak, A., & Staroń, R. (2014) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.5604/17322693.1102284 · Cited by 9
“Wzrost natężenia erytropoezy wpływa na zmniejszenie syntezy hepcydyny przez czynniki GDF15 (growth differentiation factor 15) i TWSGI (twisted gastrulation I), które są syntetyzowane w erytroblastach [94,95].”
BackgroundIbrahim, I. A., Mohamad, U. M., Darweesh, H. A., & Rashad, A. (2014) · The Egyptian Journal of Internal Medicine · doi:10.4103/1110-7782.132882 · Cited by 9
Shafarin, J., Bajbouj, K., El-Serafi, A. T., Sandeep, D., & Hamad, M. A. (2016) · Biology and Medicine · doi:10.4172/0974-8369.1000356 · Cited by 9
“Increased demand for iron downregulates hepcidin synthesis by upregulating the transcription of hypoxia inducible factor 1α (HIF-1α) [2] and the growth differentiation factor 15 (GDF15) [3] among other mechanism [4].”
BackgroundRecent advances in the management of Thalassaemia: A Review Update
Sarker, N. R., Ghosh, A. K., Saha, S. K., & Shahriar, A. (2017) · Journal of Shaheed Suhrawardy Medical College · doi:10.3329/jssmc.v6i1.31490 · Cited by 8
Regulation of Iron Absorption and Distribution
Latunde-Dada, G. O., & Simpson, R. J. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-462-9_2 · Cited by 8
“…and the liver (site of hepcidin production) is unclear but may involve plasma diferric transferrin levels or some other factor (e.g. 5-amino laevulinic acid (Laftah, Raja, Simpson, & Peters, 2003; Laftah et al., 2003, 2004) or erythropoietic factors such as GDF15 (Tanno et al., 2007)).”
BackgroundMalaria and dyserythropoiesis: a mini review
Liu, F., & Li, K. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1679337 · Cited by 10
“Co-culture experiments further demonstrated that polychromatic erythroblasts exposed to malaria parasites up-regulate GDF15 (Tamez et al., 2011), a cytokine known to suppress hepcidin and thereby exacerbate ineffective erythropoiesis (Tanno et al., 2007; Guimaraes et al., 2015).”
Elahi, P., Ahmad, M. I., & Falasca, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26030874 · Cited by 7
“…synthesis is enhanced by high iron levels, infection, and inflammation, but inhibited by erythropoiesis in the bone marrow via ERFE [18,22] and growth differentiation factor-15 (GDF-15) [23]. inhibited by erythropoiesis in the bone marrow via ERFE [18,22] and growth factor-15 (GDF-15) [23].”
Eisfeld, A., Krahl, R., Jaekel, N., Niederwieser, D. W., & Al‐Ali, H. K. (2012) · PubMed · Cited by 7
The Role of Estrogen Signaling in Cellular Iron Metabolism in Pancreatic β Cells
Taneera, J., Ali, A., & Hamad, M. A. (2022) · Pancreas · doi:10.1097/mpa.0000000000001978 · Cited by 8
“Increased demand for cellular iron induces the hypoxia inducible factor 1α (HIF1α) and the growth differentiation factor 15 to reduce hepcidin synthesis.(21,22) In fact, mice deficient for HIF1α tend to express hepcidin at much higher levels relative to wild-type counterparts.”
BackgroundCan biomarkers predict myocardial iron overload in children with thalassemia major?
Karakaş, H., Eroğlu, A. G., Akyel, N. G., Çığ, G., Adaletli, İ., Özdemir, N., Türkkan, E., & Celkan, T. T. (2023) · Cardiology in the Young · doi:10.1017/s1047951122004206 · Cited by 7
Serum growth differentiation factor-15 analysis as a malnutrition marker in hemodialysis patients
Turgut, D., Topçu, D. İ., Alperen, C. C., & Baskın, E. (2021) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-2103-62 · Cited by 7
“Cardiovascular diseases [2], ineffective erythropoiesis [3], such chronic diseases as rheumatoid arthritis, endstage renal failure, and diabetes [1], and many cancers [4] are associated with a high GDF-15 level.”
BackgroundHegde, N. V., Unger, E. L., Jensen, G. L., Hankey, P. A., & Paulson, R. F. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00463.2010 · Cited by 7
“Using a transcriptional profiling approach during erythropoiesis, GDF15 was previously found to be upregulated in thalassemic serum and is known to suppress hepcidin expression in vitro (33).”
BackgroundErythroferrone: the missing link in β-thalassemia?
Moura, I. C., & Hermine, O. (2015) · Blood · doi:10.1182/blood-2015-09-665596 · Cited by 7
Métabolisme du fer : physiologie et pathologie
Beaumont, C., & Girot, R. (2010) · Encyclopédie médico-chirurgicale. Hématologie · doi:10.1016/s1155-1984(10)49948-3 · Cited by 8
Bucak, İ. H., Almış, H., Benli, S., & Turğut, M. (2017) · Hemoglobin · doi:10.1080/03630269.2017.1337033 · Cited by 7
“Second, iron deposition occurs due to frequent erythrocyte transfusions [4,16].”
BackgroundFrýdlová, J., Rogalsky, D. W., Truksa, J., Nečas, E., Vokurka, M., & Krijt, J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0215028 · Cited by 7
Metadata
- Authors
- Tanno, T., Bhanu, N. V., Oneal, P. A., Goh, S.-H., Staker, P., Lee, Y. T., Moroney, J. W., Reed, C. H., Luban, N. L., Wang, R.-H., Eling, T. E., Childs, R., Ganz, T., Leitman, S. F., Fucharoen, S., & Miller, J. L.
- Affiliations
- National Institutes of Health (US)
- Walter Reed National Military Medical Center (US)
- Children's National (US)
- University of California, Los Angeles (US)
- Mahidol University (TH)
- Corresponding author
- Miller, Jeffery L
- Venue
- Nature Medicine
- Published
- 2007-08-26
- Volume
- 13
- Issue
- 9
- Pages
- 1096-1101
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2107423980
- Cited by
- 854
- References
- 32
- Citations by year
- 2026: 15 · 2025: 19 · 2024: 15 · 2023: 26 · 2022: 27 · 2021: 52 · 2020: 40 · 2019: 37 · 2018: 44 · 2017: 45 · 2016: 47 · 2015: 55 · 2014: 55 · 2013: 54 · 2012: 53
- FWCI
- 40.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › GDF15 and Related Biomarkers
- Keywords
- GDF15, growth differentiation factor 15, beta-thalassemia, hepcidin, iron overload, erythropoiesis, erythroblasts, soluble transferrin receptor, ferritin, erythropoietin, hepatocytes, iron regulation
- MeSH terms
- Gene Expression Regulation, Humans, Reference Values, RNA, Messenger, Thalassemia, Transcription, Genetic, Polymerase Chain Reaction, Cytokines, Gene Expression Profiling, Antimicrobial Cationic Peptides, Growth Differentiation Factor 15, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.